ID: ALA2146502

Max Phase: Preclinical

Molecular Formula: C29H40N6O2S

Molecular Weight: 536.75

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCN(CC[C@H]1CC[C@H](NC(=O)c2cccc(-c3noc(CC)n3)c2)CC1)[C@H]1CCc2nc(N)sc2C1

Standard InChI:  InChI=1S/C29H40N6O2S/c1-3-15-35(23-12-13-24-25(18-23)38-29(30)32-24)16-14-19-8-10-22(11-9-19)31-28(36)21-7-5-6-20(17-21)27-33-26(4-2)37-34-27/h5-7,17,19,22-23H,3-4,8-16,18H2,1-2H3,(H2,30,32)(H,31,36)/t19-,22-,23-/m0/s1

Standard InChI Key:  YQCXZAHQXAHRBR-VJBMBRPKSA-N

Associated Targets(non-human)

Dopamine D3 receptor 1050 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine receptor D2 and D3 225 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 536.75Molecular Weight (Monoisotopic): 536.2933AlogP: 5.29#Rotatable Bonds: 10
Polar Surface Area: 110.17Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 10.66CX LogP: 5.68CX LogD: 2.57
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.36Np Likeness Score: -1.83

References

1. Chen J, Levant B, Wang S..  (2012)  High-affinity and selective dopamine D₃ receptor full agonists.,  22  (17): [PMID:22871578] [10.1016/j.bmcl.2012.07.003]

Source